|
08
Dec
2016
Adcock Ingram sells stake in AyrtonBy:Creamer Media Contributing Editor Online PHARMACEUTICALS The Ghana Securities and Exchange Commission (SEC) has approved the sale of South African pharmaceuticals manufacturer Adcock Ingram’s 53% interest in Ghana-based pharmaceuticals company Ayrton Drug Manufacturing. Adcock Ingram noted in June that it would sell this stake to Dannex, another Ghanaian pharmaceuticals group.
This content is only available to subscribers.
Forgot your password? Click here
Don't have any login details?
Free Trial Access
|
Hydrogen 2024: Implementation crucial going forward
Buy Report
Roads, Rail & Ports 2024: Inefficiencies reach new lows
Buy Report
Africa Mining Projects in Progress 2024
Buy Report
Iron-Ore 2023/24: Bracing for change
Buy Report
Platinum Group Metals 2023: Crucial Element in the Energy Transition
Buy Report
Automotive 2023: Navigating change
Buy Report
ACSA infrastructure investment plan, South Africa
Published: 03 May 24
Red Sands battery energy storage solutions project, South Africa
Published: 03 May 24
Bankenveld District City development, South Africa
Published: 03 May 24
Despite recent efforts to bolster electricity generation capacity, the path to energy security remains full of obstacles. The integration of...
